{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:26:32Z","timestamp":1761989192930,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.hpb.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T08:43:38Z","timestamp":1526633018000},"page":"685-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Research gaps and unanswered questions in gallbladder cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"Kjetil","family":"S\u00f8reide","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewen M.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Wigmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2018.03.006_bib1","first-page":"427","article-title":"Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers","volume":"16","author":"Torre","year":"2018","journal-title":"Clin Gastroenterol Hepatol \u2013 Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.hpb.2018.03.006_bib2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.hpb.2017.05.010","article-title":"Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis","volume":"19","author":"Ghidini","year":"2017","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2018.03.006_bib3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","article-title":"New horizons for precision medicine in biliary tract cancers","volume":"7","author":"Valle","year":"2017","journal-title":"Canc Discov"},{"key":"10.1016\/j.hpb.2018.03.006_bib4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1477-2574.2012.00544.x","article-title":"Role of radical surgery in patients with stage IV gallbladder cancer","volume":"14","author":"Kang","year":"2012","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2018.03.006_bib5","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ejso.2013.10.014","article-title":"Locally advanced gallbladder cancer: which patients benefit from resection?","volume":"40","author":"Birnbaum","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2018.03.006_bib6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ejso.2016.12.008","article-title":"A\u00a0retrospective analysis of the clinical effects of neoadjuvant combination therapy with full-dose gemcitabine and radiation therapy in patients with biliary tract cancer","volume":"43","author":"Kobayashi","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2018.03.006_bib7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2016.12.058","article-title":"Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes","volume":"224","author":"Creasy","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2018.03.006_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/hpb.12444","article-title":"Gallbladder cancer: expert consensus statement","volume":"17","author":"Aloia","year":"2015","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2018.03.006_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1477-2574.2012.00559.x","article-title":"A\u00a021-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?","volume":"15","author":"Hari","year":"2013","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2018.03.006_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.hpb.2016.11.006","article-title":"Does a second resection provide a survival benefit in patients diagnosed with incidental T1b\/T2 gallbladder cancer following cholecystectomy?","volume":"19","author":"Watson","year":"2017","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2018.03.006_bib11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s11605-017-3436-8","article-title":"Predicting residual disease in incidental gallbladder cancer: risk stratification for modified treatment strategies","volume":"21","author":"Creasy","year":"2017","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2018.03.006_bib12","first-page":"109 (7)","article-title":"Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival","volume":"2017","author":"Mitin","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X18307810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X18307810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:11:31Z","timestamp":1761264691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X18307810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1365182X18307810"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2018.03.006","relation":{},"ISSN":["1365-182X"],"issn-type":[{"type":"print","value":"1365-182X"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research gaps and unanswered questions in gallbladder cancer","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}